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ABSTRACT OF THE DISSERTATION
THE EFFECT OF METHYLPHENIDATE ON ASSOCIATIVE LEARNING AMONG
YOUTH WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
by
Amy R. Altszuler
Florida International University, 2019
Miami, Florida
Professor William E. Pelham, Jr., Major Professor
Despite strong evidence supporting the short-term efficacy of interventions for
youth with Attention-Deficit/Hyperactivity Disorder (ADHD), and despite the fact that
the majority of youth with ADHD receive treatment for the disorder at some point over
the course of childhood, the long-term prognosis for individuals with ADHD remains
poor. One potential explanation for the gap between short-term efficacy and long-term
outcomes is that the most common intervention for youth with ADHD, stimulant
medication, paradoxically undermines children’s abilities to learn from contingencies
through their action on the dopaminergic system. The dynamic dopamine theory posits
that by increasing levels of dopamine, stimulant medication enhances reward-based
learning but prevents phasic dips in dopamine necessary for punishment-based learning
to occur. The current study explored the hypothesis that stimulant medication undermines
punishment-based learning among school-aged youth diagnosed with ADHD using an
associative learning task. The study used a 4 (stimulant medication dose: placebo, low,
moderate, high) x 2 (trial type: reward, punishment) x 2 (punishment condition: regular,
enhanced) design to evaluate children’s ability to learn stimuli-category associations
following reward and punishment. On reward-based trials, participants earned points
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following correct associations and received no feedback following incorrect associations.
On punishment trials, participants lost points (20 in the regular condition, 100 in the
enhanced condition) following incorrect associations and received no feedback following
correct associations. Results indicated that there was no significant main effect of
medication on children’s associative learning. Rather, children demonstrated better
overall performance in response to rewards regardless of medication condition. Children
performed worse when they received the enhanced punishment condition, an effect that
was moderated by higher doses of medication. Results indicate that other factors, aside
from dopamine levels, likely contribute to associative learning among youth with ADHD.
Specifically, the punishment to reward ratio is likely an important factor that should be
considered when designing interventions for youth with ADHD.
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INTRODUCTION
Attention-Deficit/Hyperactivity Disorder (ADHD) is a chronic
neurodevelopmental disorder affecting approximately 10% of children and adolescents in
the U.S. (Danielson, Bitsko, et al., 2018). The core symptoms of ADHD – inattention,
hyperactivity, and impulsivity, lead to significant impairment across domains of daily life
functioning, including home, school, and peer settings (Barkley, 2015; Fabiano et al.,
2006). For the majority of individuals diagnosed with ADHD, symptoms continue to
cause significant educational, financial, occupational and interpersonal problems in
young adulthood (Altszuler et al., 2015; Barkley, Murphy, & Fischer, 2008; Gordon &
Fabiano, 2019; Hechtman et al., 2016; Kuriyan et al., 2013), and for a subset of
individuals ADHD develops into more serious impairments during adolescence and
young adulthood, including substance abuse and criminality (Merrill et al., 2019; Molina
& Pelham, 2014; Sibley et al., 2011). The prevalence and persistence of ADHD-related
problems across several areas of functioning places a large economic burden on society,
with recent cost estimates in the U.S. ranging from $143 - $266 billion annually (Doshi et
al., 2012). Understanding how to best intervene with youth with ADHD to reduce lifelong impairment associated with the disorder is therefore not only a matter of critical
importance to individuals with ADHD and their families, but also a major public health
concern.
Attention-Deficit/Hyperactivity Disorder remains a prevalent and costly problem
despite decades of research supporting the significant acute benefits of interventions for
the disorder, including stimulant medication, behavioral interventions (e.g., behavioral
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parent training, behavioral classroom management) and their combination (Evans,
Owens, & Bunford, 2014; Evans, Owens, Wymbs, & Ray, 2017; Fabiano et al., 2009;
Macphee, Altszuler, Merrill, & Pelham, 2017; Pelham & Fabiano, 2008; Pliszka, 2007;
Wolraich et al., 2011). Importantly, whereas stimulant medication is the most common of
these treatments, with 90% of children with the disorder receiving stimulant treatment at
some point in their lifetime (Danielson, Visser, Chronis-Tuscano, & DuPaul, 2018), no
long-term benefits associated with stimulant medication has been documented in the
literature. Stimulant effects are only apparent as long as the medication has a
pharmacological effect (4 to 12 hours depending on the formulation; Pelham et al., 2001).
Further, there do not appear to be any residual benefits associated with taking medication.
In the Multimodal Treatment Study of ADHD (MTA), the largest longitudinal study of
ADHD treatment to date, children who received stimulant medication outperformed those
who received behavioral treatment alone at the initial 14-month assessment (MTA
Cooperative Group, 1999), but by the 24-month assessment the benefit of medication
over behavioral treatment decreased by 50% (MTA Cooperative Group, 2004) and by the
36-month assessment there was no measurable benefit of medication over behavioral
intervention (Jensen, Arnold, Swanson, Vitiello, & Abikoff, 2007).
It is surprising that medication does not produce long-term benefits, as it has large
acute effects on domains that would be expected to lead to improvements in long-term
functioning, such as on-task behavior, compliance, and academic productivity (Chronis,
Pelham, Gnagy, Roberts, & Aronoff, 2003; Fabiano et al., 2007; Greenhill, 2002;
Kortekaas-Rijlaarsdam, Luman, Sonuga-Barke, & Oosterlaan, 2019; Pelham et al., 2014;
Prasad et al., 2013). However, the effect of stimulants on areas of functioning in which
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skill development is required is much more limited, including academic achievement
(Barbaresi, Katusic, Colligan, Weaver, & Jacobsen, 2007; Massetti et al., 2008; Tamm et
al., 2017), social functioning (Altszuler et al., 2017; Hoza et al., 2005; Pelham & Bender,
1982; Whalen & Henker, 1991) and parenting (Wells et al., 2006). These findings
suggest that despite improving behavior and attention in the short-term, medication does
not help children to develop the competencies needed (e.g., ability to learn academic
concepts, social skills) to successfully navigate their schooling and interpersonal
relationships, which are key predictors of long-term outcomes (Altszuler, Page, et al.,
2015; Kuriyan et al., 2013; Molina et al., 2012).
The lack of stimulant effects in key domains and on long-term functioning
provides clear rationale for the use of behavioral interventions (Altszuler, Macphee, et al.,
2015; Macphee et al., 2017; Pelham, 2008). In contrast to medication, behavioral
interventions target the development of skills by teaching the key adults in a child’s life
(e.g., parents, teachers) to reinforce appropriate behavior through the use of praise and
rewards and to reduce inappropriate behavior through the use of punishments and
privilege removal (Evans, Owens, & Bunford, 2014; Kaminski, Valle, Filene, & Boyle,
2008; Pelham & Fabiano, 2008). Behavioral interventions produce positive effects on
behavior and attention that are similar in magnitude to those produced by stimulants
(Fabiano et al., 2007; Pelham et al., 2016; Pelham et al., 2014), and parents prefer
treatment plans that include behavioral intervention (Schatz et al., 2015; Waschbusch et
al., 2011). The use of behavioral intervention as a stand-alone treatment remains quite
low compared to medication (likely a result of costs and complexity associated with
implementing quality behavioral intervention), but the use of behavioral interventions in
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combination with stimulant medication has risen significantly in recent years (Danielson,
Visser, et al., 2018), and is currently the most commonly recommended intervention by
leading professional organizations (Pliszka, 2007; Wolraich et al., 2011).
Recent trends supporting the combination of behavioral intervention and
medications appear promising for improving long-term outcomes of youth with ADHD.
When medication and behavioral interventions are combined, low doses of both
modalities can achieve the same effects as high doses of either unimodal treatment
(Fabiano et al., 2007; Pelham et al., 2014). Using low intensity treatments is likely more
palatable than using high intensity interventions to parents and teachers (e.g., Coles et al.,
under review). Using low doses of medication reduces side effects (Fabiano et al., 2007;
Pelham, Manos, et al., 2005), and low intensity behavioral interventions are less costly
and take less parent and teacher time to implement (Page et al., 2016). Therefore,
combined interventions, relative to unimodal treatment, may improve long-term
adherence. Further, there is some evidence that combined intervention allows for both
symptom reduction and skill development (Altszuler et al., 2017; Tamm et al., 2017),
which should lead to better long-term outcomes. However, the mechanisms by which
combined interventions achieve their effects is not well understood, and the literature
documenting long-term effects of behavioral and combined interventions is limited.
Recent evidence collected in our laboratory suggests that stimulant medication
may paradoxically undermine the effects of behavioral interventions, which may help
explain why despite the large, acute effects of stimulant medication and combined
interventions, and despite most individuals with ADHD receiving these interventions at
some point during childhood, the long-term prognosis for individuals with ADHD
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remains poor. Our laboratory recently completed a within-subjects crossover study in
which children received intensive behavioral intervention combined with either stimulant
medication or placebo for three weeks, and then received the opposite medication
condition during the subsequent three weeks (Pelham at el., in preparation). Children who
initiated treatment with combined intervention (i.e., stimulant medication plus intensive
behavioral intervention) had twice as many negative verbalizations (i.e., talking back to
adults, teasing peers) per day after medication was withdrawn compared to children who
initiated treatment with placebo. The difference was observed despite the fact that
children in the medication-first condition exhibited very low rates of negative
verbalizations while taking medication. These results suggest that having medication
onboard while participating in behavioral interventions reduces learning from behavioral
contingencies. Post-hoc analyses of an earlier study conducted in our laboratory
similarly suggest that the presence of medication interferes with response to intensive
behavioral intervention (Chronis et al., 2004). Given the benefits associated with the use
of combined interventions discussed above, understanding the mechanism by which
stimulant medication may interfere with behavioral interventions is crucial for
understanding how to improve long-term functioning among youth with ADHD.
The neurobiological literature suggests that stimulants may interfere with
children’s ability to learn from contingencies in their environment, such as those
manipulated in behavioral interventions, through their action on the dopaminergic system
(Frank, 2005). Stimulants increase tonic and phasic levels of the neurotransmitter
dopamine (Schiffer et al., 2006; Volkow et al., 2001), functioning of which is depressed
among individuals with ADHD (Ernst, Zametkin, Matochik, Jons, & Cohen, 1998;

5

Volkow et al., 2007; Volkow, Wang, & Baler, 2011). Dopaminergic function is central to
creating behavior-consequence associations (Schultz, 1998) in that phasic activations of
dopamine in response to rewards result in learned behavior-reward associations over time
(Cohen, Haesler, Vong, Lowell, & Uchida, 2012; Fiorillo, Newsome, & Schultz, 2008),
whereas phasic dips following punishment (Cohen et al., 2012; Ungless, Magill, &
Bolam, 2004) result in learned avoidance of negative consequences (Frank, 2005).
Stimulant medications increase levels of dopamine (Schiffer et al., 2006; Volkow et al.,
2012; Volkow et al., 2001), which has been shown to enhance reward-based learning
among adults with ADHD (e.g., Frank, Santamaria, O’Reilly, & Willcutt, 2007).
However, by increasing dopamine levels, stimulant use may also prevent punishmentinduced phasic dips in dopamine from reaching the level necessary to effectively shape
behavior (Frank, 2005), an effect that has been consistently found among patients with
Parkinson’s Disease taking medication to increase dopamine levels (Bodi et al., 2009;
Frank, O’Reilly, & Seeberger, 2004).
Stimulant-induced insensitivity to punishment learning has not yet been evaluated
among youth with ADHD, but if supported, would have significant clinical implications.
Interventions that include punishment-based components (e.g., reprimands, point or
privilege loss) more effectively reduce disruptive behavior and increase academic
productivity than those relying on reward-based strategies alone (Abramowitz, O’Leary,
& Rosén, 1987; Acker & O’Leary, 1987; Rosen, O’Leary, Joyce, Conway, & Pfiffner,
1984), and have been found to result in better maintenance of on-task behavior (Sullivan
& O’Leary, 1990). Therefore, if children fail to learn behavior-consequence associations
while taking stimulant medication, they may face serious difficulties once stimulant
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treatment is no longer active. The possibility that stimulant medication interferes with
behavior-consequence associations is particularly worrisome given that the majority of
individuals desist stimulant use during adolescence (McCarthy et al., 2009; Molina et al.,
2009), a developmental period during which behavioral interventions are often less
effective (Evans et al., 2014, 2017). Further, a recent study of treatment sequencing found
that initiating treatment with stimulant medication reduces later uptake of behavioral
intervention (Pelham et al., 2016). Therefore, failure to learn behavior-consequence
associations during times of active stimulant use may result in youth with ADHD missing
a critical window for developing the skills necessary for long-term success.
Research Objectives and Hypotheses
The current study aims to evaluate the impact of stimulant medication,
specifically methylphenidate (MPH), on the ability of children with ADHD to learn from
punishment and reward using a laboratory-based computer task. The first aim of the
current study is to evaluate whether MPH impairs punishment-based learning on an
associative learning task (Bodi et al., 2009). It is hypothesized that MPH will impair
punishment-based learning as evidenced by lower accuracy on punishment-based
learning trials compared to reward-based trials of the task when youth are taking MPH in
contrast to similar performance across these trial types when taking a placebo. The
second aim is to investigate whether the dose of MPH differentially impacts punishmentbased learning by comparing accuracy on punishment-based and reward-based trials
across MPH doses. It is hypothesized that the effect of MPH will be dose-dependent such
that higher doses of MPH will impair punishment-based learning to a greater extent than
will lower doses of MPH. The final aim is to evaluate whether the intensity of

7

punishment moderates the effect of MPH on punishment-based learning. It is
hypothesized that the effect of MPH on punishment-based learning will be attenuated
when punishment is intensified, as evidenced by increased accuracy on punishment-based
trials of the associative learning task in an enhanced punishment condition relative to a
regular punishment condition.

8

METHODOLOGY
Participants
Participants were 27 children between the ages of 7 and 12 (M = 8.72 years)
diagnosed with DSM-IV ADHD-Combined subtype (ADHD-C) who were referred to
clinical services at the Center for Children and Families (CCF) at FIU. Children were
referred to the CCF by local professionals or schools, media advertisements, billboards,
or parent self-referral. Participation was limited to children who met criteria for ADHD-C
because models of dopamine dysfunction best account for the profile of impairment
experienced by these individuals, rather than by children who meet criteria for the
predominately inattentive or hyperactive/impulsive subtypes (Johansen, Sagvolden, Aase,
& Russell, 2005). Sample characteristics are displayed in Table 1.
Evaluations of ADHD were made according to standard assessment procedures in
the field (Pelham, Fabiano, & Massetti, 2005). Specifically, symptoms of ADHD,
oppositional defiant disorder (ODD) and conduct disorder (CD), were assessed using the
NIMH Diagnostic Interview Schedule for Children IV, computerized version (Shaffer,
2000), and parent and teacher ratings on the Disruptive Behavior Disorders Scale (DBD;
Pelham, Gnagy, Greenslade, & Milich, 1992). Cross-situational impairment was assessed
using parent and teacher ratings on the Impairment Rating Scale (IRS; Fabiano et al.,
2006). Two doctoral level clinicians independently reviewed intake assessments to make
diagnoses for each child who participated in the study. Twenty-four participants received
a concurrent diagnosis of ODD and no participants were diagnosed with CD.
Children were excluded from the study on the basis of the following criteria: (1) a
Full Scale IQ below 80 according to the Wechsler Abbreviated Scale of Intelligence,
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Second Edition (WASI-II; Wechsler, 2011); (2) receiving psychotropic medication for
conditions other than ADHD or active medical or psychiatric conditions that could be
worsened by stimulants at the time of study enrollment; (3) documented intolerance to
MPH medications; (4) concurrent diagnosis of DSM-5 Autism Spectrum Disorder (ASD)
as stimulants have been found to have reduced efficacy and tolerability in this population
(Research Units on Pediatric Psychopharmacology (RUPP) Autism Network, 2005); and
(5) comorbid conditions requiring psychotropic medication or emergent treatment (e.g.,
mania, active suicidal ideation).
One participant withdrew from the study because of scheduling conflicts resulting
from the parent’s work schedule, partial data were collected and analyzed. All other
participants completed the study.
Procedures
The study was approved by the Western Institutional Review Board (Protocol #:
20161191). Participants provided informed consent/assent prior to the implementation of
study procedures. All children underwent an initial assessment to determine
appropriateness for the study, which included an evaluation of ADHD, ODD and CD, a
brief cognitive assessment, and a physical exam clearing participants to be prescribed
stimulant medications.
Setting. The study was conducted within a Saturday Treatment Program (SatTP), an
8-week behavioral peer intervention for children with ADHD modeled after the Summer
Treatment Program (Pelham et al., 2010). The SatTP was held for 3 hours on Saturday
mornings and afternoons, and sessions were held approximately one week apart. Children
were placed in 3 groups of 10 to 15, supervised by 5 to 7 paraprofessional counselors.
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Counselors were supervised by an advanced doctoral student and a licensed clinical
psychologist. Children participated in recreational activities (e.g., soccer drills and
games) and cooperative learning activities. Staff members implemented a comprehensive
behavior management system throughout the SatTP.
Design. The study used a 4 (medication: placebo; MPH: 0.15, 0.3, 0.6 mg/kg/dose) x
2 (trial type: reward, punishment) x 2 (task condition: regular punishment, enhanced
punishment) within-subjects design to evaluate MPH and punishment manipulations on
children’s ability to learn associations from rewards and punishments. Study conditions
were randomly assigned across the 8 days of the SatTP, such that each child received one
condition per program day. Table 2 displays a sample study schedule for one participant.
Medication. Doses of MPH that most closely approximate 0.15, 0.3, and 0.6
mg/kg/dose and placebo were randomized by day over a total of the 8 days of the SatTP.
The doses used in the current study represent standard dosing for low, moderate, and high
doses of MPH respectively (Fabiano et al., 2007; Pelham et al., 2014; Pelham, Manos, et
al., 2005). Order of medication condition was counter-balanced across participants. A
portion of participants (n = 11), were participating in a concurrent medication study in
which they were prescribed long-acting MPH on weekends, when study testing sessions
were conducted. Ten of these children were prescribed OROS-MPH (Concerta) and one
was prescribed Metadate CD. All other participants were prescribed immediate-release
MPH. Long-acting and short-acting forms of MPH have been shown to have equivalent
effects on children’s attention, behavior, and productivity (Döpfner et al., 2004; Pelham
et al., 2001; Swanson et al., 2004). Testing sessions were conducted within the timecourse for the appropriate formulation of MPH.
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Parents were provided dated blister packs containing medication capsules,
sequenced according to the randomization schedule. Medication administration was
confirmed by SatTP staff with parents at the start of each program day. Parents were also
asked to return used blister packs as a check on medication adherence. Medication was
delivered in a gelatin capsule so that participants, their parents, and staff members were
not aware of medication condition. Adverse effects were monitored daily through parent
and staff ratings on the Pittsburgh Side Effect Rating Scale (Pelham, 1993), a measure
that has been routinely used in medication studies conducted within the STP (e.g.,
Pelham et al., 1999, 2001, 2005, 2014). No adverse events were reported during the
study.
Task Procedures. One testing session was conducted per SatTP day. Task
conditions were randomized by day and order was counter-balanced across participants.
On four days, participants received the enhanced punishment condition and on four days
participants received the regular punishment condition (Table 2). The computer task was
administered individually to each child by a research assistant on a Dell laptop. The
sessions were conducted in a quiet room and lasted approximately 15 minutes.
Participants sat at a comfortable viewing distance from the laptop. Participants wore
headphones and computer volume was kept at a standard level for all testing sessions.
Associative Learning Task. A modified version of a probabilistic learning task
previously used by Bodi et al. (2009) to measure the impact of dopamine on associative
learning among adults with Parkinson’s Disease was used in the current study. The task
measures participants’ ability to learn stimuli-category associations through trial and
error (see Table 3 for a description of the task structure). Stimuli were four kaleidoscopic

12

images, selected at random from a library of over 250 images (see Figure 1 for sample
images). Unique images were presented during each testing session. Two of the four
images presented during each testing session belonged to category “A” and the remaining
two images belonged to category “B.” One image from each category was associated
with rewards (reward trials), such that participants earned points when they matched the
image to the appropriate category. The remaining two images (one belonging to category
“A” and one belonging to category “B”) were associated with punishment (punishment
trials), such that participants lost points when images were matched to the incorrect
category. Punishment and reward trials were interspersed throughout each testing session.
Two different punishment trial types were tested during unique testing sessions: regular
and enhanced punishment (described in more detail below). Probabilistic feedback was
provided across trial types, meaning that participants received accurate feedback on 80%
of trials and inaccurate feedback on 20% of trials. Probabilistic feedback was introduced
because pilot testing among youth ages 7-11 diagnosed with ADHD-C resulted in mean
task performance above 80% across reward and punishment trial types, indicating
potential ceiling effects (Altszuler, Macphee et al., 2016). Probabilistic feedback has been
used in previous studies (Bodi et al., 2009; Frank et al., 2007; Mattfeld, Gluck, & Stark,
2011) to introduce variability in task performance and to prevent ceiling effects.
Each testing session consisted of 160 learning trials (40 trials/image) split into
four consecutive testing blocks. The order of stimuli was counterbalanced across
participants. Each testing session began with the presentation of one of the four images
with the question “Is this an ‘A’ or a ‘B’?” below the image, followed by the two possible
categories. Stimuli were presented until the participant responded and trials were
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separated by the presentation of a blank page for 1000 msec. Participants’ point totals
were displayed in the bottom right corner of the screen and were updated continuously
depending on performance. On reward trials (Figure 1, Panel A), participants earned 20
points when the correct category was selected. To mimic feedback a child might receive
from a parent or teacher (e.g., verbal praise, positive facial expression), point gain was
associated with visual and audio feedback. Participants were presented with “+20” in
green text, a happy face icon, and the “cha-ching” sound of a cash register. When the
incorrect category was selected, participants did not receive any feedback or lose points.
Across both punishment conditions (i.e., regular and enhanced), participants did not
receive any feedback when the correct category was selected on punishment trials (Figure
1, Panels B and C). In the regular punishment condition, participants lost 20 points when
the incorrect category was selected. Point loss was accompanied with visual and audio
feedback, including “-20” presented in red text, a red sad face image, and a buzzer sound
(Figure 1, Panel B). These punishments were intensified in the enhanced punishment
condition such that participants lost 100 points, accompanied by “-100” presented in red
text, a red angry face icon, and an airhorn sound (Figure 1, Panel C).
Prior to testing, task administrators provided participants with standardized
instructions for completing the task. Participants were told they would be learning to
match pictures to the correct letter. Category and trial types were explained to
participants. Participants were also told that they would receive inaccurate feedback at
times. Participants were instructed to keep as many points as possible and were shown all
potential prizes for which points could be exchanged upon completion of the task.
Participants were provided with one practice block prior to the first testing session to
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ensure understanding of task procedures. During task administration, research assistants
provided redirection if children engaged in off-task behavior and provided positive
feedback for effort, but did not provide performance feedback. At the end of the task,
children exchanged points for prizes, which ranged in point value depending on
desirability.
Dependent Measure
Performance on the probabilistic learning task was analyzed as the dependent
measure. Total correct categorizations out of total possible trials was calculated for each
trial type (i.e., reward, punishment).
Analyses and Handling of Missing Data
Multilevel modeling (Hayes, 2006) was used to analyze the effect of study
manipulations on task performance, with 128 observations per child (i.e., reward and
punishment trial performance across 4 blocks per testing session, across 8 testing
sessions). The model was fit for task performance on both trial types. Initial models
indicated that the order of testing condition (e.g., condition received on day 5 versus day
8) and other potential covariates, including participant IQ, age, race, and ethnicity, failed
to explain variance in task performance and were therefore dropped from the final model.
Initial analyses also indicated that the interaction of block and study manipulations (i.e.,
punishment condition, medication dose) did not explain variance in task performance and
those interactions were also dropped from model specification.
In the final model, trial performance was regressed on a random factor for child
and several fixed effects: (a) medication dose (i.e., placebo, 0.15 mg/kg, 0.3 mg/kg, 0.6
mg/kg), (b) trial type (i.e., reward or punishment), (c) punishment condition (i.e., regular

15

or enhanced), (d) block, (e) the interaction of trial type and punishment condition, (f) the
interaction of medication dose and trial type, (g) the interaction of medication dose and
punishment condition, (h) the three-way interaction of medication, trial type, and
punishment condition, and (i) the interaction of block and trial type. The effects testing
study aims are (f) and (h). Effect (f) evaluates Aims 1 and 2: Does medication
differentially impact learning from punishment compared to reward? Effect (h) evaluates
Aim 3: Does dose of punishment moderate the effect of MPH on punishment learning?
Multilevel models were conducted in SPSS 20.0. Where models indicated statistically
significant effects, simple slope regressions (Preacher, Curran, & Bauer, 2006) were
conducted using the reghelper package in R.
Overall, 13.4% of task performance data were missing as a result of participant
absences (10.6%) or non-adherence to medication condition (2.8%). The multilevel
modeling framework handles unbalanced observations on the outcome variable for data
missing at random.

16

RESULTS
Table 4 displays raw means and standard deviations of task performance by trial
type, punishment condition, and medication dose. Table 5 displays results of the multilevel
model.
Learning Over Time
The effect of study manipulations on task performance was evaluated over the
course of four blocks per testing session to assess learning over time. There was no
significant direct effect of task block; however, there was a significant block by trial type
interaction (p <0.05). As displayed in Figure 2, children’s learning improved over time on
punishment trials (Block 1 marginal mean= 0.52, Block 4 marginal mean= 0.59), whereas
children’s initial performance on reward trials was more accurate relative to punishment
trials (Block 1 marginal mean=0.62) and remained consistent throughout testing (Block 4
marginal mean=0.64), t (1438) = 4.51, p <0.001.
Direct Effects of Study Manipulations
There was no significant direct effect of medication, nor any significant medication
by trial type (i.e., reward, punishment) interactions. That is, medication did not improve
children’s associative learning on punishment- or reward-based learning trials.
There was a significant direct effect of trial type (p <0.001) such that children
associated more stimuli with the correct categories on reward trials (marginal mean=0.62)
compared to punishment trials (marginal mean=0.57). However, as mentioned above, there
was a significant block by trial type interaction, such that this effect was no longer
significant by block 4, t (328) = -0.48, p = 0.64.
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There was a significant direct effect of punishment condition (p<0.01), such that
children’s task performance improved across trial types (i.e., reward and punishment) when
they received the regular punishment condition (marginal mean=0.61) compared to the
enhanced condition (marginal mean=0.58).
Interaction of Medication, Trial Type, and Punishment
The three-way interaction of medication, trial type, and punishment condition was
significant for the moderate dose of MPH (p <0.01) and was trending towards significance
for the high dose (p<0.10). Simple slopes regressions indicated that higher doses of
medication (0.3 and 0.6 mg/kg MPH) had a differential effect on reward trial performance
when participants received the enhanced punishment condition (Figure 3, Panel A).
Specifically, in the enhanced punishment condition, participants performed significantly
worse on reward trials when prescribed placebo (marginal mean= 0.55), t (1438) = 3.26, p
< 0.01, and 0.15 mg/kg MPH (marginal mean= 0.58), t (1438) = 3.11, p < 0.01, compared
to their performance when they received the regular punishment condition (placebo
marginal mean= 0.64, 0.15 mg/kg marginal mean= 0.66). The same effect was not observed
for punishment trials (Figure 3, Panel B).
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DISCUSSION
The current study evaluated the impact of MPH on associative learning among
youth with ADHD. The study measured the effect of four doses of MPH (i.e., placebo,
low, moderate, and high) and two punishment conditions (i.e., regular and enhanced) on
children’s performance across reward- and punishment-based trial types on an associative
learning task. Overall, results did not support hypotheses that stimulant medication
interferes with children’s punishment-based learning, and results indicated that this effect
was not seen at any dose of medication. The study similarly did find support for
intensifying punishment as a method for enhancing punishment-based learning. Across
conditions, children performed only slightly above chance levels (averaging 62%
accuracy on reward trials and 57% accuracy on punishment trials), indicating that the
probabilistic nature of the task may have been too difficult to detect planned effects.
Results did indicate that children demonstrated better overall performance when they
were rewarded for correct responses relative to when they were punished for incorrect
responses, regardless of medication status. Further, results indicated worse performance
under more intensive punishment conditions, a finding that was attenuated by higher
doses of medication. These findings, and their implications, are discussed in turn below.
Lack of Main Effects of Medication
The lack of a significant main effect of MPH in the current study is surprising,
given that stimulant medication has been shown to improve performance of youth with
ADHD on a variety of laboratory tasks (e.g., Bubnik, Hawk, Pelham, Waxmonsky, &
Rosch, 2015; Groen, Mulder, Wijers, Minderaa, & Althaus, 2009; Rosch et al., 2015;
Strand et al., 2012). According to Frank’s (2005) dynamic dopamine model, stimulant
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medication would be expected to improve performance on reward-based trials as a result
of increased dopamine levels, as has been observed with adults with Parkinson’s Disease
(Bodi et al., 2009; Frank, O’Reilly, & Seeberger, 2004) and adults with ADHD (Frank et
al., 2007). Failure to find a stimulant effect on reward-based learning in the current study
may have been caused by limited variability in reward-based trial performance over time.
Across punishment conditions, block 4 learning on reward trials averaged approximately
58% accuracy when participants were unmedicated and ranged from 60-65% accuracy
when participants were taking medication. In comparison, unmedicated adults with
ADHD performed similarly low (approximately 60% accuracy) when learning from
reward-based stimuli, but medication improved performance to approximately 75%
accuracy on a similar task (Frank et al., 2007). The current study is the first to use such a
probabilistic learning paradigm in children, and the lack of learning over time in response
to rewards suggests that the task may have been too difficult for children to achieve over
65% accuracy on reward-based trials.
Following the dynamic dopamine model (Frank, 2005), stimulant medication
would also be expected to impair punishment-based learning by blocking phasic dips in
dopamine levels, an effect that was not observed in the current study. Frank and
colleagues (2007) also failed to show that medication impaired punishment-based
learning among individuals with ADHD, to which authors attributed to a floor effect as
participants only demonstrated optimal responding to punishment-based stimuli about
60% of the time. A floor effect may also explain lack of findings in the current study as
punishment-based learning averaged approximately 57% accuracy across conditions.
However, learning from punishment did improve significantly over time, and whereas
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medication status did not moderate learning rate in the current study, it is possible that
additional learning opportunities may have produced sufficient variability in performance
to detect a medication effect.
While task calibration appears to be a probable explanation for the failure of the
current study to support Frank’s dynamic dopamine model, it is also likely that factors
other than stimulant-induced dopamine levels influenced reward- and punishment-based
performance on the associative learning task. Other potential contributing factors are
discussed below.
Differences in Punishment- and Reward-Based Learning
In the current study, children demonstrated higher overall performance when they
were rewarded for correct responses compared to when they were punished for incorrect
responses on the associative learning task. These results differ from findings in the
behavioral intervention literature, which show that punishment-based strategies,
including the loss of points and privileges, are more effective at shaping behavior than
are reward-based strategies (Abramowitz et al., 1987; Acker & O’Leary, 1987; Pfiffner &
O’Leary, 1987; Rosen et al., 1984). However, the relatively large initial difference in
performance across punishment and reward trials observed in the current study
(approximately 11 percentage points), decreased by more than half by the last block of
the task and the difference between the two trial types was no longer statistically
significant by block 4. That is, despite understanding reward-stimuli associations better at
the outset, children demonstrated more learning over time in response to punishment
stimuli, tempering conclusions that children with ADHD learn better from rewards.
Given that the rate of punishment-based learning increased over time while reward-based
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learning remained consistent, it is possible that accuracy on punishment-based stimuli
would have continued to improve and perhaps match or surpass accuracy on rewardbased stimuli with additional learning trials. However, as mentioned above, it is also
possible that performance on reward trials was stilted by task difficulty. Adding
additional learning opportunities and increasing the percentage of accurate feedback on
future iterations of the task may help provide clarity regarding the effectiveness of
punishment- and reward-based learning strategies for children with ADHD.
The differential rate of learning from punishment and reward observed in the
current study is interesting, as the effect has not been found in studies using the same task
with other populations (Bodi et al., 2009; Mattfeld et al., 2011), or in the behavioral
intervention literature (Acker & O’Leary, 1987; Iwata & Bailey, 1974; Pfiffner &
O’Leary, 1987; Rosen et al., 1984). The task experience, particularly the experience of
receiving no feedback, may have contributed to the differential learning rate across trial
types. When children correctly matched images to the appropriate category on reward
trials, they received immediate feedback that they were correct. That is, they only had to
make a “one-step” association that Image 1 equaled “A.” In contrast, on punishment
trials, children received feedback when they were incorrect, meaning they had to process
that 1) Image 2 did not equal “B,” and that 2) Image 2 therefore equaled “A.” Relative to
the one-step process of learning reward-stimuli associations, the two-step process of
learning punishment-stimuli associations may have therefore placed greater working
memory demands on children, an area that is quite impaired for children with ADHD
(Kasper, Alderson, & Hudec, 2012). The no feedback condition likely added even greater
working memory demands, as no feedback could either mean that children incorrectly
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associated an image to a category on a reward trial or correctly associated an image to a
category on a punishment trial, meaning that children had to remember 1) whether the
image was associated with reward or punishment and 2) to which category the image
belonged. Separating punishment and reward trials into different testing sessions may
help reduce the cognitive load experienced by children when completing the task,
allowing for greater clarification beyond the current study regarding the trial type from
which children with ADHD learn best.
The probabilistic learning task used in the current study attempted to tease apart
effects from rewards and punishments by associating feedback types to different images
within a testing session. However, reward and cost components were still mixed in the
current study such that point losses and gains contributed to the same total point bank,
which participants exchanged for desirable prizes at the end of the session. The overall
task experience therefore mirrored a token economy, in which children earn points for
positive behavior and lose points for inappropriate behaviors, and points are then
exchanged for privileges and rewards (Altszuler, Macphee, et al., 2015). While such
procedures represent contingencies implemented as a part of good clinical practice for
youth with ADHD (Evans et al., 2017), combining reward and punishment trials within a
single testing session may have also contributed to difficulties teasing apart learning
effects from reward versus cost strategies, as has been found in the behavioral
intervention literature (Iwata & Bailey, 1974; Kaufman & O’Leary, 1972; McGoey &
DuPaul, 2000). Further separating rewards and consequences into separate testing
sessions may help address these limitations.
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While it is unclear which strategy led to better learning in the current study,
children did respond (albeit in different ways) to both reward- and punishment-based
strategies. Findings related to reward- and punishment-based learning suggest that,
consistent with common clinical recommendations, both reward- and punishment-based
strategies should be used in the treatment of children with ADHD. Punishment and
reward strategies are both widely recognized components of effective behavioral
interventions for youth with ADHD and disruptive behavior problems (DuPaul, Eckert, &
Vilardo, 2012; Kaminski et al., 2008), and all widely used behavioral parenting programs
teach caregivers to use both positive reinforcement and punishment strategies, such as
time out and privilege removal (e.g., Barkley, 2013; Cunningham et al., 1993; McMahon
& Forehand, 2005).
Differences by Punishment Condition
It was hypothesized that intensifying punishment would lead to better learning, as
doing so would lead to a larger phasic dip in dopamine (Schultz, 1998), counteracting the
effect of stimulant-induced increases in dopamine. The current study is the first to
evaluate the interaction of differing intensities of punishment and stimulant medication,
and support was not found for this hypothesis. In contrast, participants performed worse
overall when they received the enhanced punishment condition, which consisted of a loss
of 100 points accompanied by an angry face and unpleasant sound, compared to when
they received the regular punishment condition, which consisted of a loss of 20 points
accompanied by a less aversive face and sound.
Interestingly, the deterioration of learning in the enhanced punishment condition
was driven nearly entirely by performance on reward trials, on which participants
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performed approximately 4 percentage points worse in the enhanced condition. In
contrast, there was little difference in punishment trial performance across the enhanced
and regular punishment conditions. Learning deterioration in the enhanced punishment
condition suggests that in the context of a more frustrating experience, children had more
difficulty learning from reward-based stimuli. Children may have shown reduced
performance on reward trials because performance on such trials was less meaningful in
the enhanced punishment condition, as children only earned 20 points relative to losing
100 points. The fact that punishment condition influenced reward performance indicates
that the overall task experience influenced children’s ability to learn from rewards and
punishments, providing additional support for separating punishment and reward testing
sessions, as discussed above.
Children were able to maintain their performance on punishment trials (relative to
reward trials) when they received the enhanced punishment condition, indicating that
they were likely somewhat more motivated to avoid a large point loss. However, the
presence of the enhanced punishment condition negatively impacted children’s overall
performance. It is likely (and was observed anecdotally), that children became more
frustrated when they received the enhanced punishment condition. Overly strong
punishments and criticisms, particularly relative to the strength of rewards, lead to
increases in disruptive behavior and poorer behavioral outcomes (Musser, Karalunas,
Dieckmann, Peris, & Nigg, 2017; Patterson, 2002). Children with ADHD are also more
likely to give up in the face of frustration (Milich, 1994; Milich & Okazaki, 1991), which
may have contributed to poorer performance on reward trials in the enhanced punishment
condition relative to the regular punishment condition.
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Medication, Punishment Condition, and Trial Type Interaction
As mentioned above, participants performed worse on reward trials when they
received the enhanced punishment condition. However, deterioration of reward-based
learning was attenuated by medication such that at moderate and high doses (0.3 – 0.6
mg/kg MPH), participants performed similarly across enhanced punishment (marginal
means ranged from 63 – 66% accuracy) and regular punishment (marginal means ranged
from 62 – 65% accuracy) conditions. In contrast, when participants were taking a placebo
or a low dose (0.15 mg/kg MPH), they fared worse when they received the enhanced
punishment (marginal means ranged from 55 – 58% accuracy) relative to when they
received the regular punishment (marginal means ranged from 64 – 66% accuracy).
These findings indicate that higher doses of medication helped offset the negative effects
of the enhanced punishment condition on reward trial performance.
These findings are consistent with previous work examining the impact of
stimulant medication on persistence among youth with ADHD. Previous work by Milich
and colleagues (1991) demonstrated that children with ADHD performed the same on a
solvable task when taking a moderate dose of medication (0.3 mg/kg MPH) relative to
placebo. However, when given a frustrating task (a nonsense word search), children were
much better able to persist when taking medication, and performed better on subsequent
solvable puzzles, relative to their performance when taking placebo. Similarly, Pelham
and colleagues (1997) found that a moderate dose (0.3 mg/kg MPH) improved
persistence and reaction to failure among children with ADHD, and that research
assistants (unaware of child medication status) rated children taking medication as
putting forth more effort. Findings from the current study add to the literature that
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medication provides a buffering effect when youth with ADHD are faced with frustrating
situations.
Limitations
The current study was the first to evaluate stimulant-induced insensitivity to
punishment-based learning among youth with ADHD and study limitations may help
explain why support was not found for Frank’s (2005) dynamic dopamine model among
youth with ADHD. The current study was also the first to use the probabilistic learning
task with children, and findings suggest that the task calibration used in the current study
was likely too challenging for participants’ developmental level. While learning did
appear to occur from both trial types (as evidenced by better initial performance on
reward trials and significantly improved learning over time on punishment trials), the
highest accuracy achieved across conditions was 65%. Providing a higher percentage of
accurate feedback will lead to better task performance (Altszuler, Macphee, et al., 2016),
and might allow for detection of medication effects. It also appears that additional
learning opportunities would have been helpful, particularly for punishment-based trials,
as learning appeared to follow a linear trajectory and performance may have continued to
improve with additional trials. As discussed previously, it is also possible that the
differing cognitive loads posed by reward and punishment trials served as a confound,
and that mixing punishment and reward trials in the same testing session influenced task
performance. Limitations associated with the task development should be taken into
account when designing future studies to evaluate the impact of stimulant medication on
associative learning among youth with ADHD.
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In addition to limitations associated with the task, the study sample was small and
may have been underpowered to detect smaller effects. However, previous research
indicates that medication should have relatively large effects on task performance
(Bubnik et al., 2015; Rosch et al., 2015; Strand et al., 2012). Further, the use of a withinsubjects design increases power and did allow for the detection of several significant
effects in the current study. As with most studies conducted with youth with ADHD, the
study sample was predominately male, and as with most studies conducted in South
Florida, participants were predominately Hispanic/Latino. Study results may therefore
lack generalizability.
Clinical Implications
The present study has several implications relevant to the treatment of children
with ADHD. First, children learned from both reward- and punishment-based strategies,
supporting current clinical recommendations to use both forms of behavior modification
with youth with ADHD. Findings also highlight the importance of ensuring that reward
and punishment-based strategies are balanced. When children lost more points than they
earned, their performance was affected, likely due to frustration. Findings are in line with
clinical recommendations to provide positive feedback at a higher frequency than
negative redirections (Altszuler, Macphee, et al., 2015), because, as was seen in the
current study, overly negative feedback results in worse behavior. Further, tasks that are
too challenging may result in children giving up altogether (Milich et al., 1991; Milich &
Okazaki, 1991). Consistent with past research, findings from the current study also
indicate that stimulant medication improves performance among youth with ADHD when
faced with frustrating or challenging tasks. These findings indicate that it can be helpful
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to have medication onboard when children must face challenging or frustrating tasks.
However, psychosocial interventions aimed at improving frustration management and
teaching parents and teachers to set achievable goals for youth with ADHD have also
been found to be effective (Kolko, Lindhiem, Hart, & Bukstein, 2014; Waxmonsky et al.,
2016), and as discussed previously, interventions that teach skills are likely to lead to
better long-term functioning.
Conclusions and Future Directions
Findings from the current study failed to support hypotheses that stimulant
medication would impair punishment-based learning, and that enhanced punishment
would attenuate these effects. One explanation for failure to find support for hypotheses
is that the associative learning task used in the current study was not ideally calibrated to
youth with ADHD. Due to this limitation, the hypothesis that medication interferes with
punishment-based learning cannot be ruled out. Future work should continue to examine
this hypothesis among youth with ADHD using suggested modifications to the current
task to allow for more variability in task performance and to better isolate effects from
reward- and punishment-based learning. Should support be found for this mechanism in a
lab-based setting, it will be crucial to conduct studies in clinical settings to better
understand how findings translate to clinical practice recommendations for youth with
ADHD. Many factors influence contingency-based learning among youth with ADHD,
and findings from the current study suggest that emotion regulation and working memory
likely play a role. Future work should continue to explore how these variables impact
children’s response to behavioral interventions and stimulant medication. Lastly, many
factors likely contribute to the gap between short-term efficacy and positive long-term
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outcomes for youth with ADHD, including poor long-term adherence to treatment,
reduced motivation to implement behavioral interventions following stimulant treatment,
and lack of resources for/availability of chronic models of care for individuals with
ADHD. More work targeting the development of long-term services for individuals with
ADHD and engagement in such services is sorely needed to improve the long-term
prognosis of these individuals.
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Table 1
Sample Characteristics
Age M (SD)
Gender (% Male)
Ethnicity (%)
Hispanic
Non-Hispanic
Did not respond
Race (%)
White
African American
Multi-racial
Highest Parental Education (%)
Less than high school
High school or GED
Partial college
Associate’s degree
Bachelor’s degree
Graduate training or degree
Estimated Full-Scale IQ M (SD)
ODD Diagnosis (%)
CD Symptoms M (SD)
Note. n = 27

8.72 (1.70)
77.8
81.5
14.8
3.7
77.8
14.8
7.4
3.7
14.8
7.4
14.8
33.3
25.9
96.81 (13.02)
88.9
0.85 (0.91)
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Table 2
Sample Participant Testing Schedule
Day
Medication
Punishment Condition
1
Placebo
Enhanced
2
0.3 mg/kg MPH
Regular
3
0.15 mg/kg MPH
Enhanced
4
Placebo
Regular
5
0.6 mg/kg MPH
Enhanced
6
0.15 mg/kg MPH
Regular
7
0.6 mg/kg MPH
Regular
8
0.3 mg/kg MPH
Enhanced
Note. MPH = Methylphenidate
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Table 3
Task Structure by Trial Type and Punishment Condition
RP Condition
Probability “A” (%) Probability “B” (%)
Image 1
80
20
Image 2
20
80
Image 3
80
20
Image 4
20
80
EP Condition
Probability “A” (%) Probability “B” (%)
Image 1
80
20
Image 2
20
80
Image 3
80
20
Image 4
20
80
Note. RP = Regular Punishment, EP = Enhanced Punishment.
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Trial Type
Reward
Reward
Punishment (Regular)
Punishment (Regular)
Trial Type
Reward
Reward
Punishment (Enhanced)
Punishment (Enhanced)

Table 4
Raw Means and Standard Deviations for Dependent Measures
Punishment
Placebo
Outcome
Condition
M (SD)
Reward trial performance

Punishment trial performance

0.15 mg/kg MPH
M (SD)

0.3 mg/kg MPH
M (SD)

0.6 mg/kg MPH
M (SD)

RP

0.59 (0.23)

0.62 (0.21)

0.63 (0.21)

0.64 (0.22)

EP

0.55 (0.22)

0.58 (0.20)

0.64 (0.22)

0.63 (0.18)

RP

0.56 (0.15)

0.58 (0.12)

0.57 (0.19)

0.57 (0.18)

EP

0.57 (0.17)

0.57 (0.15)

0.56 (0.14)

0.56 (0.16)

Note. RP = Regular Punishment, EP = Enhanced Punishment. Models were conducted on estimated marginal means. Raw
means and standard deviations are presented for ease of interpretation. Means represent the average percentage of correct
stimuli-category associations per session.
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Table 5
Results of Multilevel Model for Task Performance
Term
Intercept

Estimate
0.62

SE
0.03

t
22.13

p
<0.001

95% CI
0.56, 0.67

Punishment Trial Type (vs. Reward)

-0.13

0.03

-4.04

<0.001

-0.19, -0.06

EP Condition (vs. RP)

-0.09

0.02

-3.26

<0.01

-0.13, -0.03

0.15 mg/kg MPH (vs. Placebo)

0.02

0.02

0.95

ns

-0.03, 0.07

0.3 mg/kg MPH (vs. Placebo)

-0.02

0.02

-0.74

ns

-0.07, 0.03

0.6 mg/kg MPH (vs. Placebo)

0.01

0.03

0.16

ns

-0.05, 0.05

Punishment Trial*EP Condition

0.09

0.03

2.66

<0.01

0.02, 0.16

Punishment Trial*0.15 mg/kg MPH

-0.01

0.03

-0.27

ns

-0.08, 0.06

Punishment Trial*0.3 mg/kg MPH

0.04

0.03

1.04

ns

-0.03, 0.10

Punishment Trial*0.6 mg/kg MPH

-0.01

0.04

-0.01

ns

-0.07, 0.07

EP Condition*0.15 mg/kg MPH

0.01

0.03

0.04

ns

-0.07, 0.07

EP Condition* 0.3 mg/kg MPH

0.11

0.03

3.17

<0.01

0.04, 0.18

EP Condition*0.6 mg/kg MPH

0.06

0.04

1.79

<0.10

-0.01, 0.13

Punishment Trial* EP Condition*0.15 mg/kg MPH

-0.01

0.05

-0.16

ns

-0.10, 0.09

Punishment Trial*EP Condition*0.3 mg/kg MPH

-0.13

0.05

-2.65

<0.01

-0.22, -0.03

Punishment Trial*EP Condition* 0.6 mg/kg MPH

-0.08

0.05

-1.72

<0.10

-0.18, 0.01

Block

0.01

0.01

1.09

ns

-0.01, 0.02

Punishment Trial*Block
0.02
0.01
2.42
<0.05
0.01, 0.03
Note. SE = standard error. EP = Enhanced Punishment. RP = Regular Punishment. All binary variables were coded as dummy
variables (e.g., Punishment Trial = 0, Reward Trial = 1).
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Figure 1
Task Feedback by Trial Type and Punishment Condition
a. Reward

b. Regular Punishment

c. Enhanced Punishment

Correct Selection

Incorrect Selection

Note. Accurate feedback is depicted for demonstration purposes. Sample image for Reward and Regular
Punishment trials belonged to Category “B.” Sample image for Enhanced Punishment trials belonged to Category
“A.”
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Figure 2
Task Learning by Punishment Condition and Trial Type

Note. Task performance is measured by the percentage of correct stimuli-category associations
per testing session.
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Figure 3
Task Performance by Trial Type, Punishment Condition, and Medication Dose

Note. RP = Regular Punishment. EP = Enhanced Punishment. Task performance is measured by the percentage of correct
stimuli-category associations per testing session.
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